← Leaderboards
Gary Jay Brenner
Massachusetts General Hospital
$3,851,453
Attributed
$4,200,518
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $794.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,200,518 · 4
By mechanism
R01$1,802,905 · 1
K08$853,390 · 1
R21$846,093 · 1
R41$698,130 · 1
Top collaborators
- Susan X Luo2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Xandra Owens Breakefield$30,735,276
- Vijaya Ramesh$9,458,883
- Lei Xu$1,353,153
- Anat Olga Stemmer-Rachamimov$1,001,767
- Allen C Steere$11,999,334
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsInnovationMediatingTumorCessation Of LifeMedicalNeurilemmomaNerveCellsToxic EffectNovel TherapeuticsImmuneVirusNeoplastic CellGrantCause Of DeathCell DeathCell LineageApoptoticImplantInflammatoryInjection Of Therapeutic AgentDisabilityCasp1 Gene
Grant awards (14)
Salmonella typhimurium-based Bacteriotherapy for Orphan Benign Tumors: Neurofibromatosis Type II (NF2)$198,603
R41 · FY2021 · NS
Salmonella typhimurium-based Bacteriotherapy for Orphan Benign Tumors: Neurofibromatosis Type II (NF2)$499,527
R41 · FY2020 · NS
Translation of AAV P0 ICE schwannoma gene therapy to clinical Trials$415,109
R21 · FY2016 · NS · contact PI
Mechanisms of Caspase-1 Mediated Schwannoma Regression$363,790
R01 · FY2016 · NS · contact PI
Translation of AAV P0 ICE schwannoma gene therapy to clinical Trials$430,984
R21 · FY2015 · NS · contact PI
Mechanisms of Caspase-1 Mediated Schwannoma Regression$363,790
R01 · FY2015 · NS · contact PI
Mechanisms of Caspase-1 Mediated Schwannoma Regression$360,151
R01 · FY2014 · NS · contact PI
Mechanisms of Caspase-1 Mediated Schwannoma Regression$351,058
R01 · FY2013 · NS · contact PI
Mechanisms of Caspase-1 Mediated Schwannoma Regression$364,116
R01 · FY2012 · NS · contact PI
NMDA Receptor Phosphorylation and Trafficking after Pain$170,678
K08 · FY2006 · NS · contact PI
NMDA Receptor Phosphorylation and Trafficking after Pain$170,678
K08 · FY2005 · NS
NMDA Receptor Phosphorylation and Trafficking after Pain$170,678
K08 · FY2004 · NS
NMDA Receptor Phosphorylation and Trafficking after Pain$170,678
K08 · FY2003 · NS
NMDA Receptor Phosphorylation and Trafficking after Pain$170,678
K08 · FY2002 · NS